Regulacje i polityka gospodarcza · 16.11.1995

Changes to the Testing Cutoff Levels for Opiates for Federal Workplace Drug Testing Programs

The Department of Health and Human Services (HHS) is proposing to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs, 59 FR 29916 (June 9, 1994). Specifically, the Department is proposing to change the drug testing levels currently used to test for opiate metabolites in urine specimens collected as part of the Federal Workplace Drug Testing Program and to require the testing for a metabolite of heroin. The goals of the proposed new opiate testing policy are to substantially reduce the number of laboratory opiate positives that Medical Review Officers ultimately verify as negative, shift the emphasis of opiate testing back to the proper focus to deter and detect heroin use, and reduce any unnecessary/excessive costs to drug testing without compromising the original drug deterrent objectives.